(Q37617853)

21 August 2017

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? (English)

1 reference

21 August 2017

0 references

M Allen

6

0 references

Koleka Mlisana

object named as

K Mlisana

4

0 references

Zoe Moodie

7

object named as

Z Moodie

1 reference

21 August 2017

G E Gray

1

1 reference

21 August 2017

B Metch

2

1 reference

21 August 2017

G Churchyard

3

1 reference

21 August 2017

M Nchabeleng

5

1 reference

21 August 2017

J Kublin

8

1 reference

21 August 2017

L-G Bekker

9

1 reference

21 August 2017

HVTN 503 team

10

1 reference

21 August 2017

language of work or name

English

0 references

publication date

29 January 2013

1 reference

21 August 2017

1 reference

21 August 2017

31

1 reference

21 August 2017

16

1 reference

21 August 2017

2089-2096

1 reference

Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Risk compensation: the Achilles' heel of innovations in HIV prevention?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Changes in sexual risk behavior among participants in a prep hiv prevention trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Preventive misconception: its nature, presence, and ethical implications for research.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942784

Therapeutic misconception in clinical research: frequency and risk factors

1 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.031

Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.031

Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.031

Low acceptability of medical male circumcision as an HIV/AIDS prevention intervention within a South African community that practises traditional circumcision.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.031

10.1016/J.VACCINE.2013.01.031

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

1 reference